Barbara Rizzardi is Principal Investigator. OpenAlex indexes 13 publications with 717 citations (h-index 9); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 3 Nov 2026
Overview
Updated 5 Nov 2026
Barbara Rizzardi, MD, is Principal Investigator. The public record shows 13 publications with 717 citations (h-index 9). It also documents an investigator role on 1 registered clinical trials, industry payments reported by 10 companies.
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 5 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Clinical trials
Updated 5 Nov 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults
Sponsor: ILiAD Biotechnologies
Industry payments
Updated 5 Nov 2026
10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Hoffmann-La Roche LimitedProgram year20254 payments$11,580openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20258 payments
- Merck Sharp & Dohme LLCProgram year20259 payments
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Most-cited works
by citation count (OpenAlex)- 01
- 02Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of AgeArticle140 citations2022
- 03Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant HypertensionArticle106 citations2025
- 04
- 05
Network
Updated 5 Nov 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 5 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →velocityclinical.com ↗
- Medical degree
University of Nevada School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →velocityclinical.com ↗ - Internal medicine residency and internship
LDS Hospital, Salt Lake City, UT
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →velocityclinical.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
Richard Casaburi, MD
University of California, Los Angeles